Rivian Stock Under Time: Is Now the Buying Opportunity
Rivian is targeting a major production shift with the R2 lineup. This guide weighs the bull and bear cases for rivian...
An overview of potential yields from stablecoins, including yield farming, interest accounts, and risk considerations to optimize income.
27,570 articlesRivian is targeting a major production shift with the R2 lineup. This guide weighs the bull and bear cases for rivian...
Trilogy Metals stock tanked after a tepid earnings release, shaking confidence in a company that explores copper, gol...
A prominent investment advisor added a sizable CMPX position, signaling strong conviction in Compass Therapeutics. He...
A big stake in Sotera Health has caught the market's eye as shares slide. This article breaks down what a $175 millio...
Rivian stock may get a lift not just from its R2 ramp but from a larger tech ecosystem catalyst: the potential SpaceX...
Oklo stock fell further as traders digested quarterly results and a new regulatory filing. This article breaks down w...
A major share sale by Orbimed Advisors in Enliven Therapeutics coincides with a sharp stock rally. This guide breaks ...
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
A major institutional stake in TTMI has sparked fresh debates about the stock's risk and reward. This guide breaks do...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
As the clean energy shift accelerates, two hydrogen-focused leaders—Bloom Energy and Plug Power—offer distinct paths ...